BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2040871)

  • 1. Plasma chromogranin A + B, neuropeptide Y and catecholamines in pheochromocytoma patients.
    Gröndal S; Eriksson B; Hamberger B; Theodorsson E
    J Intern Med; 1991 May; 229(5):453-6. PubMed ID: 2040871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromogranin A and chromogranin B are sensitive circulating markers for phaeochromocytoma.
    Stridsberg M; Husebye ES
    Eur J Endocrinol; 1997 Jan; 136(1):67-73. PubMed ID: 9037129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromogranin A in familial pheochromocytoma: diagnostic screening value, prediction of tumor mass, and post-resection kinetics indicating two-compartment distribution.
    Hsiao RJ; Neumann HP; Parmer RJ; Barbosa JA; O'Connor DT
    Am J Med; 1990 Jun; 88(6):607-13. PubMed ID: 2189303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma neuropeptide Y immunoreactivity influences left ventricular mass in pheochromocytoma.
    Kuch-Wocial A; Slubowska K; Kostrubiec M; Pasierski T; Januszewicz W; Switalska H; Wocial B; Pruszczyk P
    Clin Chim Acta; 2004 Jul; 345(1-2):43-7. PubMed ID: 15193976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide Y in multiple endocrine neoplasia: release during surgery for phaeochromocytoma.
    Connell JM; Corder R; Asbury J; Macpherson S; Inglis GC; Lowry P; Burt AD; Semple PF
    Clin Endocrinol (Oxf); 1987 Jan; 26(1):75-84. PubMed ID: 2879655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does plasma neuropeptide-Y immunoreactivity in patients with pheochromocytoma depend on hormonal activity of the tumor?
    Pruszczyk P; Wocial B; Ignatowska-Switalska H; Feltynowski T; Ellafi M; Januszewicz A; Lapiński M; Zukowska-Grojec Z; Januszewicz W
    Clin Chim Acta; 1995 Dec; 243(2):205-12. PubMed ID: 8747495
    [No Abstract]   [Full Text] [Related]  

  • 7. The secretion of catecholamines, chromogranin A and neuropeptide Y from the adrenal medulla of the cat via the adrenolumbar vein and thoracic duct: different anatomic routes based on size.
    Carmichael SW; Stoddard SL; O'Connor DT; Yaksh TL; Tyce GM
    Neuroscience; 1990; 34(2):433-40. PubMed ID: 2333152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant pheochromocytoma. Chromaffin granule transmitters and response to treatment.
    Rao F; Keiser HR; O'Connor DT
    Hypertension; 2000 Dec; 36(6):1045-52. PubMed ID: 11116123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenal incidentaloma diagnosed as pheochromocytoma by plasma chromogranin A and plasma metanephrines.
    Miehle K; Kratzsch J; Lenders JW; Kluge R; Paschke R; Koch CA
    J Endocrinol Invest; 2005 Dec; 28(11):1040-2. PubMed ID: 16483187
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on chromogranin levels in human blood.
    Yamada R; Sato J; Komiya E
    Endocrinol Jpn; 1979 Feb; 26(1):137-40. PubMed ID: 436797
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changes in plasma catecholamines during pheochromocytoma resection (author's transl)].
    Kaneko T; Hashimoto Y; Yusa T; Miura Y
    Masui; 1979 Feb; 28(2):181-6. PubMed ID: 423357
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnostic efficacy of unconjugated plasma metanephrines for the detection of pheochromocytoma.
    Raber W; Raffesberg W; Bischof M; Scheuba C; Niederle B; Gasic S; Waldhäusl W; Roden M
    Arch Intern Med; 2000 Oct; 160(19):2957-63. PubMed ID: 11041903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma chromogranin A as a marker of sympathochromaffin activity in humans.
    Cryer PE; Wortsman J; Shah SD; Nowak RM; Deftos LJ
    Am J Physiol; 1991 Feb; 260(2 Pt 1):E243-6. PubMed ID: 1996627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunoassay of chromogranin A in plasma as a measure of exocytotic sympathoadrenal activity in normal subjects and patients with pheochromocytoma.
    O'Connor DT; Bernstein KN
    N Engl J Med; 1984 Sep; 311(12):764-70. PubMed ID: 6472366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in plasma neuropeptide Y immunoreactivity and catecholamine levels during surgical removal of pheochromocytoma.
    Januszewicz W; Wocial B; Ignatowska-Switalska H; Dutkiewicz-Raczkowska M; Feltynowski T; Januszewicz A; Tapiński M; Zukowska-Grójec Z; Szostek M
    J Hypertens; 1998 Apr; 16(4):543-7. PubMed ID: 9797201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-time heart rate variability and its correlation with plasma catecholamines during laparoscopic adrenal pheochromocytoma surgery.
    Sesay M; Tauzin-Fin P; Gosse P; Ballanger P; Maurette P
    Anesth Analg; 2008 Jan; 106(1):164-70, table of contents. PubMed ID: 18165573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromogranin A storage and secretion: sensitivity and specificity for the diagnosis of pheochromocytoma.
    Hsiao RJ; Parmer RJ; Takiyyuddin MA; O'Connor DT
    Medicine (Baltimore); 1991 Jan; 70(1):33-45. PubMed ID: 1988765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free and conjugated plasma catecholamines in hypertensive patients with and without pheochromocytoma.
    Kuchel O; Buu NT; Fontaine A; Hamet P; Beroniade V; Larochelle P; Genest J
    Hypertension; 1980; 2(2):177-86. PubMed ID: 7380521
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma catecholamine levels in the diagnosis and management of pheochromocytoma.
    Hamberger B; Arnér S; Eskilsson P; Lindvall N; Werner S; Granberg PO
    Surg Gynecol Obstet; 1981 Mar; 152(3):291-6. PubMed ID: 7466575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of plasma markers for the clinical behaviour of phaeochromocytomas.
    van der Harst E; de Herder WW; de Krijger RR; Bruining HA; Bonjer HJ; Lamberts SW; van den Meiracker AH; Stijnen TH; Boomsma F
    Eur J Endocrinol; 2002 Jul; 147(1):85-94. PubMed ID: 12088924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.